Clinical Trial Update: A Study Investigating Coagadex in the Treatment AFXD Associated With AL Amyloidosis [Phase 3]

View source ↗

Summary

A Phase 3 study evaluating Coagadex for Acquired Factor X Deficiency associated with AL amyloidosis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Factor Deficiency
• Al Amyloidosis

Drugs mentioned

• Coagadex (Factor X concentrate)

Snippet

Sponsor: Kedrion S.p.A. | Conditions: Acquired Factor X Deficiency | Phase 3 | Status: RECRUITING